Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
13
RVNC Quote, Financials, Valuation and Earnings
Last price:
$3.08
Seasonality move
:
-2.77%
Day range:
$3.07 - $3.09
52-week range:
$2.30 - $9.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.16x
P/B ratio:
--
Volume:
3.5M
Avg. volume:
3.6M
1-year change:
-59.37%
Market cap:
$323.1M
Revenue:
$234M
EPS (TTM):
-$1.94
Earnings Data
Next earnings date for RVNC
Feb 28
2025
Most recent earnings per share
-$0.37
Beat by $0.03
(Nov 7/2024)
Consensus Estimate
-$0.40
(Nov 7/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RVNC Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/28/2025 | Q4 | $73.1M | -- | -- | -$0.40 | -- |
| 11/07/2024 | Q3 | $68.2M | $59.9M | -$0.37 | -$0.40 | $0.03 |
| 08/08/2024 | Q2 | $66.3M | $65.4M | -$0.36 | -$0.45 | $0.09 |
| 05/09/2024 | Q1 | $56.7M | $51.9M | -$0.58 | -$0.83 | $0.25 |
| 02/28/2024 | Q4 | $62.1M | $79.7M | -$0.63 | -$0.92 | $0.29 |
| 11/08/2023 | Q3 | -- | -- | -$1.63 | -$0.94 | -$0.69 |
| 08/08/2023 | Q2 | -- | -- | -$0.80 | -$0.78 | -$0.02 |
| 05/09/2023 | Q1 | -- | -- | -$0.74 | -$0.84 | $0.10 |
| 02/28/2023 | Q4 | -- | -- | -$1.82 | -$1.07 | -$0.75 |
| 11/08/2022 | Q3 | -- | -- | -$1.17 | -$0.87 | -$0.30 |
| 08/09/2022 | Q2 | -- | -- | -$0.88 | -$0.90 | $0.02 |
| 05/10/2022 | Q1 | -- | -- | -$0.94 | -$0.96 | $0.02 |
| 02/28/2022 | Q4 | -- | -- | -$0.93 | -$1.03 | $0.10 |
| 11/09/2021 | Q3 | -- | -- | -$1.10 | -$1.15 | $0.05 |
| 08/05/2021 | Q2 | -- | -- | -$1.07 | -$1.07 | -$0.00 |
| 05/10/2021 | Q1 | -- | -- | -$1.08 | -$1.09 | $0.01 |
| 02/22/2021 | Q4 | -- | -- | -$1.24 | -$1.26 | $0.02 |
| 11/09/2020 | Q3 | -- | -- | -$1.34 | -$1.04 | -$0.30 |
| 08/06/2020 | Q2 | -- | -- | -$1.12 | -$1.05 | -$0.08 |
| 05/07/2020 | Q1 | -- | -- | -$1.15 | -$0.91 | -$0.24 |
| 02/24/2020 | Q4 | -- | -- | -$0.99 | -$0.97 | -$0.02 |
| 11/04/2019 | Q3 | -- | -- | -$0.96 | -$0.97 | $0.01 |
| 08/05/2019 | Q2 | -- | -- | -$0.86 | -- | -- |
| 05/08/2019 | Q1 | -- | -- | -$0.85 | -- | -- |
| 02/26/2019 | Q4 | -- | -- | -$1.12 | -- | -- |
| 11/01/2018 | Q3 | -- | -- | -$0.91 | -- | -- |
| 08/02/2018 | Q2 | -- | -- | -$0.94 | -- | -- |
| 05/08/2018 | Q1 | -- | -- | -$0.97 | -- | -- |
| 02/28/2018 | Q4 | -- | -- | -$1.14 | -- | -- |
| 11/02/2017 | Q3 | -- | -- | -$1.01 | -- | -- |
| 08/03/2017 | Q2 | -- | -- | -$0.90 | -- | -- |
| 05/08/2017 | Q1 | -- | -- | -$0.94 | -- | -- |
| 02/27/2017 | Q4 | -- | -- | -$0.95 | -- | -- |
| 11/03/2016 | Q3 | -- | -- | -$0.64 | -- | -- |
| 08/04/2016 | Q2 | -- | -- | -$0.88 | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -$0.71 | -- | -- |
| 03/02/2016 | Q4 | -- | -- | -$0.83 | -- | -- |
| 11/09/2015 | Q3 | -- | -- | -$0.81 | -- | -- |
| 08/06/2015 | Q2 | -- | -- | -$0.71 | -- | -- |
| 05/13/2015 | Q1 | -- | -- | -$0.65 | -- | -- |
| 03/02/2015 | Q4 | -- | -- | -$0.60 | -- | -- |
Revance Therapeutics Earnings Questions
-
How Much did Revance Therapeutics Generate in Revenue Last Quarter?
Revance Therapeutics reported $59.9M worth of top line sales in its most recent quarter.
-
Did Revance Therapeutics Beat Earnings Last Quarter?
Revance Therapeutics announced earnings per share of -$0.37 which represents a beat of analyst forecast a -$0.40 per share.
-
Is Revance Therapeutics Profitable?
Revance Therapeutics reported $42.2M that represents $0.41 per share over the last quarter.
-
What is the Analyst Consensus for Revance Therapeutics EPS Next Year?
Revance Therapeutics's earnings are forecast to decrease from -$3.83 per share to -$4.02 per share next year representing a decrease of -60.44%.
-
When is Revance Therapeutics's Earnings Date?
Revance Therapeutics's next earnings date is February 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 5.73% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 7.2% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 4.6% over the past day.
